Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1997-12-04
2000-06-13
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424469, A61K 926, A61K 952
Patent
active
060746696
ABSTRACT:
A pharmaceutical composition in the form of a tablet or a capsule for the controlled release of diltiazem, comprises about 30 to about 97% by weight of a hydrophilic polymer, about 0.5 to about 30% by weight of an enteric (pH-dependent) polymer, and about 2.5 to about 60% by weight of diltiazem or a pharmaceutically acceptable salt or ester thereof. The ratio of hydrophilic polymer to enteric polymer is in the range of about 1:1 to about 15:1. Such a pharmaceutical composition releases diltiazem at a rate that allows effective plasma levels of diltiazem to be maintained over a period of twenty-four hours after administration to human adult subjects.
REFERENCES:
patent: 4721619 (1988-01-01), Panoz et al.
patent: 4792452 (1988-12-01), Howard et al.
patent: 4839177 (1989-06-01), Colombo et al.
patent: 4880631 (1989-11-01), Haslam et al.
patent: 4894240 (1990-01-01), Geoghegan et al.
patent: 4917899 (1990-04-01), Geoghegan et al.
patent: 4946686 (1990-08-01), McClelland et al.
patent: 4968507 (1990-11-01), Zentner et al.
patent: 4968508 (1990-11-01), Oren et al.
patent: 4994273 (1991-02-01), Zentner et al.
patent: 5000962 (1991-03-01), Sangekar et al.
patent: 5002776 (1991-03-01), Geoghegan et al.
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5422123 (1995-06-01), Conte et al.
patent: 5470584 (1995-11-01), Hendrickson et al.
patent: 5508044 (1996-04-01), Buxton et al.
patent: 5529791 (1996-06-01), Deboeck et al.
patent: 5578321 (1996-11-01), Sherman
Nagaprasad Vishnubhotla
Sen Himadri
Deshmukh Jayadeep R.
Kulkosky Peter F.
Ranbaxy Laboratories Limited
LandOfFree
Controlled drug delivery system for diltiazem does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled drug delivery system for diltiazem, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled drug delivery system for diltiazem will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2066379